Compare BLCO & MSM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BLCO | MSM |
|---|---|---|
| Founded | 1853 | 1941 |
| Country | Canada | United States |
| Employees | 13000 | N/A |
| Industry | Ophthalmic Goods | Industrial Machinery/Components |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 6.1B | 6.7B |
| IPO Year | 2022 | 1996 |
| Metric | BLCO | MSM |
|---|---|---|
| Price | $16.94 | $128.50 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 14 | 10 |
| Target Price | $19.04 | ★ $131.00 |
| AVG Volume (30 Days) | 288.1K | ★ 560.6K |
| Earning Date | 10-28-2026 | 10-22-2026 |
| Dividend Yield | N/A | ★ 2.81% |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 3.12 |
| Revenue | ★ $5,101,000,000.00 | $3,363,817,000.00 |
| Revenue This Year | $7.71 | $5.89 |
| Revenue Next Year | $5.86 | $6.73 |
| P/E Ratio | ★ N/A | $39.87 |
| Revenue Growth | ★ 6.47 | 4.99 |
| 52 Week Low | $13.77 | $78.80 |
| 52 Week High | $18.92 | $130.46 |
| Indicator | BLCO | MSM |
|---|---|---|
| Relative Strength Index (RSI) | 49.12 | 57.17 |
| Support Level | $16.94 | $116.15 |
| Resistance Level | $17.21 | $127.25 |
| Average True Range (ATR) | 0.39 | 2.62 |
| MACD | -0.03 | 0.39 |
| Stochastic Oscillator | 45.28 | 83.94 |
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
Founded in 1941, MSC Industrial Direct originally manufactured and sold cutting tools to metalworking shops in New York. Through a series of acquisitions and organic expansions, MSC has grown into an industrial distribution powerhouse with a focus on specialized metalworking products and services. The firm also distributes a wide breadth of maintenance, repair, and operations supplies. MSC primarily operates in North America, where it derives over 95% of its revenue.